tiprankstipranks
Inhibikase Therapeutics (IKT)
NASDAQ:IKT

Inhibikase Therapeutics (IKT) Stock Investors

101 Followers
Based on 747,528 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold IKT
On average, investors allocate 0.00% of their portfolios to IKT
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 747,528 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding IKT

2.1%
Last 7
Days
5.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding IKT, out of 747,528 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

IKT Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.73%
$1.90
Based on the activity of 14,193 investors who made their portfolios public
The table shows changes in IKT in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

IKT Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.81%
-1.48%
-2.00%
32.41B
Consumer Cyclical
ChargePoint Holdings
4.17%
-1.00%
-2.43%
833.60M
Consumer Cyclical
Marathon Digital Holdings
5.78%
-0.18%
+0.20%
6.75B
Financial
Plug Power
5.02%
-1.49%
-3.21%
1.87B
Industrials
Riot Platforms
5.15%
-0.53%
+0.54%
3.47B
Financial
Coherus Biosciences
2.58%
-1.95%
-5.37%
188.15M
Healthcare
Microstrategy
7.07%
+1.56%
+7.77%
31.55B
Technology
XPeng, Inc. ADR
5.34%
-2.00%
-3.45%
7.82B
Consumer Cyclical
C3ai
6.04%
-0.45%
+2.71%
3.47B
Technology
Lucid Group
5.66%
-1.43%
-2.74%
8.08B
Consumer Cyclical
Based on the activity of 747,528 active portfolios
Open your Smart Portfolio

IKT Investor Analysis

IKT investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
15.2%
of IKT holders
are under 35
Average Segment Performance
Average P/E Ratio20.77
Beta7.15
Dividend Yield6.79%
IKT investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
21.2%
of IKT holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.59
Beta11.22
Dividend Yield6.44%
IKT investors over 55

Over 55

3.5%
Last 30 days
Holdings Change
63.6%
of IKT holders
are over 55
Average Segment Performance
Average P/E Ratio19.41
Beta3.84
Dividend Yield7.80%
Overview of age group and performance of IKT stock investors
See who invests in IKT according to age group and performance.

FAQ

How many retail Investors hold IKT?
<0.1% of TipRanks' retail investors hold IKT in their portfolios.
    What is IKT Investor Sentiment?
    IKT’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of IKT in the last 7 days?
      ▼ 2.1% of TipRanks' retail investors changed their holding of IKT in the last 7 days.
        What percentage of retail investors changed their holding of IKT in the last 30 days?
        ▼ 5.6% of TipRanks' retail investors changed their holding of IKT in the last 30 days.
          What is the average age of retail investors who hold IKT?
          The average age of IKT Holders is over 55.
            What other stocks have IKT investors also bought?
            IKT Investors also bought DKNG, CHPT, MARA, PLUG, RIOT, CHRS, MSTR, XPEV, AI, LCID.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              BCRXBioCryst
              CYTKCytokinetics
              DHRDanaher
              EWEdwards Lifesciences
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis